Hematopoietic stem cells: An overview

Transfusion and Apheresis Science

Volumn 51, Issue 3, 2014, Pages 68-82

  Mosaad, Youssef Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Aging; Application; Development; Homing; HSC; Niche; Plasticity; Separation; Trafficking

Indexed keywords

REACTIVE OXYGEN METABOLITE; TOXIC SUBSTANCE;

ADRENERGIC SYSTEM; ADULT STEM CELL; AGING; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL NUCLEUS TRANSPLANTATION; CELL SEPARATION; CELL SURFACE; CELL TRANSDIFFERENTIATION; COCULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; DNA DAMAGE; DNA MODIFICATION; EPIGENETICS; FLUORESCENCE ACTIVATED CELL SORTING; GENE THERAPY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOMAGNETIC SEPARATION; MICROENVIRONMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLASTICITY; REGENERATIVE MEDICINE; REJUVENATION; REVIEW; SENESCENCE; SOMATIC CELL; STEM CELL NICHE; STEM CELL RESEARCH; TELOMERE; UMBILICAL CORD BLOOD; ANIMAL; CELL AGING; CELL PROLIFERATION; HEMATOLOGIC DISEASES; IMMUNE SYSTEM DISEASES; METABOLISM; PATHOLOGY;

ANIMALS; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETIC THERAPY; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE SYSTEM DISEASES;

EID: 84921886088     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.10.016     Document Type: Review

References (96)

1. Sasha Sa FAQ - Stem Cells (Sa Mix) accessed 14.10.02. http://www.terry.ubc.ca/2009/08/07/faq-stem-cells-sa-mix/.
2. Attar E.C., Scadden D.T. Stem cells. Molecular hematology 2010, 26-40. Blackwell Publishing Ltd. 3rd ed. D. Provan, J.G. Gribben (Eds.).
3. Govindan R., Kumar V., Sisodia S., Mallick PJ. Molecular interactions in stem cell homing and bone marrow transplantation therapy. Int J Pharm Biomed Sci 2012, 3(4):210-213.
4. Chotinantakul K., Leeanansaksiri W. Hematopoietic Stem Cell development, niches, and signaling pathways. Bone Marrow Res 2012, 2012:270425.
5. Bellantuono I. Haemopoietic stem cells. Int J Biochem Cell Biol 2004, 36:607-620.
6. Brown J.M., Weissman I.L. Progress and prospects in hematopoietic stem cell expansion and transplantation. Editor/Exp Hematol 2004, 32:692-697.
7. Barriga F., Rojas N., Wietstruck A. Alternative donor sources for hematopoietic stem cell transplantation, innovations in stem cell Transplantation. InTech 2013, Available from:, accessed 14.10.02. http://www.intechopen.com/books/innovations-in-stem-cell-transplantation/alternative-donor-sources-for-hematopoietic-stem-cell-transplantation, 10.5772/53083. T. Demirer (Ed.).
8. Kirschstein R., Skirboll L.R. Hematopoietic stem cells. Stem cells: scientific progress and future research directions 2001, 43-58. accessed 14.10.02]. Stem Cell Information. National Institute of Health web site. http://stemcells.nih.gov/info/scireport/pages/chapter5.aspx.
9. Cohen Y., Nagler A. Umbilical cord blood transplantation - how, when and for whom?. Blood Rev 2004, 18(3):167-179.
10. Shamblott M.J., Axelman J., Littlefield J.W., Blumenthal P.D., Huggins G.R., Cui Y., et al. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci U S A 2001, 98:113-118.
11. Zech N. Adult stem cell manipulation and possible clinical perspectives. J Reproduktionsmed Endokrinol 2004, 1(2):91-99.
12. Gunsilius E., Gastl G., Petzer A.L. Hematopoietic stem cells. Biomedicine & Pharmacotherapy 2001, 55(4):186-194.
13. Hirschi K.K. Hemogenic endothelium during development and beyond. Blood 2012, 119(21):4823-4827.
14. Boisset J.C., Robin C. On the origin of hematopoietic stem cells: progress and controversy. Stem Cell Res 2012, 8:1-13.
15. Shinton N.K. Desk reference for hematology 2007, 382-396. CRC press. 2nd ed.
16. Metcalf D. Concise review: hematopoietic stem cells and tissue stem cells: current concepts and unanswered questions. Stem Cells 2007, 25(10):2390-2395.
17. Magnon C., Frenette P.S. Hematopoietic stem cell trafficking. The stem cell research community, StemBook 2008, StemBook, accessed 14.10.02. http://www.stembook.org, 10.3824/stembook.1.8.1.
18. Renström J., Kröger M., Peschel C., Oostendorp R.A. How the niche regulates hematopoietic stem cells. Chem Biol Interact 2010, 184(1-2):7-15.
19. Kanji S., Pompili V.J., Das H. Plasticity and maintenance of hematopoietic stem cells during development. Recent Pat Biotechnol 2011, 5(1):40-53.
20. Surbek D.V., Steinmann C., Burk M., Hahn S., Tichelli A., Holzgreve W. Developmental changes in adhesion molecule expressions in umbilical cord blood CD34+hematopoietic progenitor and stem cells. Am J Obstet Gynecol 2000, 183:1152-1157.
21. Samokhvalov I.M. Return to the hematopoietic stem cell origin. Cell Regener 2012, 1:1-10.
22. Szilvassy S.J. The biology of hematopoietic stem cells. Arch Med Res 2003, 34(2003):446-460.
23. Warren L.A., Rossi D.J. Stem cell and aging in the hematopoietic system. Mech Aging Dev 2009, 130:46-53.
24. Rossi D.J., Bryder D., Weissman I.L. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol 2007, 42:385-390.
25. Pelosi E., Castelli G., Testa U. Human umbilical cord is a unique and safe source of various types of stem cells suitable for treatment of hematological diseases and for regenerative medicine. Blood Cells Mol Dis 2012, 49:20-28.
26. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010, 11:585-593.
27. Alenzi F.Q., Alenazi B.Q., Ahmad S.Y., Salem M.L., Al-Jabr A.A., Wyse R.K.H. The haemopoietic stem cell: between apoptosis and self renewal. Yale J Biol Med 2009, 82(1):7-18.
28. Ema H., Nakauchi H. Self-renewal and lineage restriction of hematopoietic stem cells. Curr Opin Genet Dev 2003, 13:508-512.
29. Mahmud N., Milhem M., Araki H., Hoffman R. Alteration of hematopoietic stem cell fates by chromatin-modifying agents. Stem cell transplantation. Biology, processing, and therapy 2006, 27-42. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. A.D. Ho, R. Hoffman, E.D. Zanjani (Eds.).
30. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. 1993 81: 2844-53.
31. Walasek M.A., van Os R., de Haan G. Hematopoietic stem cell expansion: challenges and opportunities. Ann N Y Acad Sci 2012, 1266:138-150.
32. Li Z., Li L. Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 2006, 31(10).
33. Oh I.H., Kwon K.R. Concise review: multiple niches for hematopoietic stem cell regulations. Stem Cells 2010, 28(7):1243-1249.
34. Nwajei F., Konopleva M. The bone marrow microenvironment as niche retreats for hematopoietic and leukemic stem cells. Adv Hematol 2013, 2013:953982.
35. Nakano T. Hematopoietic stem cells: generation and manipulation. Trends Immunol 2003, 24(11).
36. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
37. Hoggatt J., Pelus L.M. Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment. Stem Cell Res Ther 2011, 2:13.
38. Leeman D.S., Brunet A. Stem cells: sex specificity in the blood. Nature 2014, 505(7484):488-490.
39. Zapata A.G., Wislet-Gendebien S. The adult hematopoietic niches - cellular composition, histological organization and physiological regulation, adult stem cell niches. InTech 2014, Available from:, accessed 14.10.03. http://www.intechopen.com/books/adult-stem-cell-niches/the-adult-hematopoietic-niches-cellular-composition-histological-organization-and-physiological-regu, 10.5772/58634.
40. Dimitrov S., Benedict C., Heutling D., Westermann J., Born J., Lange T. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 2009, 113(21):5134-5143.
41. Mendez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452(7186):442-447.
42. Scheiermann C., Kunisaki Y., Lucas D., Chow A., Jang J.E., Zhang D., et al. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity 2012, 37(2):290-301.
43. Perry J.M., Li L. To be or not to be a stem cell: dissection of cellular and molecular components of haematopoietic stem cell niches. EMBO J 2012, 31:1060-1061.
44. Martinez-Agosto J.A., Mikkola H.K., Hartenstein V., Banerjee U. The hematopoietic stem cell and its niche: a comparative view. Genes Dev 2007, 21:3044-3060.
45. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
46. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
47. Lapidot T., Dar A., Kollet O. How do stem cells find their way home?. Blood 2005, 106:1901.
48. Hidalgo A. Hematopoietic stem cell homing: the long, winding and adhesive road to the bone marrow. Inmunología 2008, 27(1):22-35.
49. Bik To L., Levesque J.P., Herbert K.E. How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011, 118(17).
50. Suárez-Álvarez B., López-Vázquez A., López-Larrea C. Mobilization and homing of hematopoietic stem cells. Stem cell transplantation 2012, 2012 Landes Bioscience and Springer Science+Business Media. C. López-Larrea, A. López-Vázquez, B. Suárez-Álvarez (Eds.).
51. Herbert K.E., Levesque J.P., Mills A.K., et al. How we mobilize haemopoietic stem cells. Intern Med J 2011, 41:588-594.
52. Reddy V. Granulocyte colony-stimulating factor mobilization alters dendritic cell cytokine production and initiates T helper 2 polarization prior to host alloantigen presentation. Blood 2000, 96(7):2635.
53. Ho A.D., Wagner W., Mahlknecht U. Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine. EMBO Rep 2005, 6:35-38.
54. Wagner W., Horna P., Borka S., Ho A.D. Aging of hematopoietic stem cells is regulated by the stem cell niche. Exp Gerontol 2008, 43(11):974-980.
55. Allsopp R.C., Morin G.B., DePinho R., Harley C.B., Weissman I.L. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 2003, 102:517-520.
56. Greenwood M.J., Lansdorp P.M. Telomeres, telomerase, and hematopoietic stem cell biology. Arch Med Res 2003, 34:489-495.
57. Kamming L.M., de Haan G. Cellular memory and hematopoietic stem cell aging. Stem Cells 2006, 24(5):1143-1149.
58. Geiger H., Haan G., Florian M.C. The ageing haematopoietic stem cell compartment. Nat Rev Immunol 2013, 13:376-389.
59. Zanta G.V., Liang Y. Concise review: hematopoietic stem cell aging, life span, and transplantation. Stem Cells Transl Med 2012, 1(9):651-657.
60. Kenyon J., Gerson S.L. The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res 2007, 35:7557-7565.
61. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447:725-729.
62. Fujisaki J., Wu J., Carlson A.L., et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 2011, 474(7350):216-219.
63. Zheng J., Song C., Zhang C.C. A new chapter: hematopoietic stem cells are direct players in immunity. Cell Biosci 2011, 1:33.
64. Jaiswal S., Chao M.P., Majeti R., Weissman I.L. Macrophages as mediators of tumor immunosurveillance. Trends Immunol 2010, 31(6):212-219.
65. Jaiswal S., Jamieson C.H., Pang W.W., Park C.Y., Chao M.P., Majeti R., et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009, 138(2):271-285.
66. Francisco L.M., Sage P.T., Sharpe A.H. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010, 236:219-242.
67. Zou W., Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008, 8(6):467-477.
68. Wognum A.W., Eaves A.C., Thomas T.E. Identification and isolation of hematopoietic stem cells. Arch Med Res 2003, 34(6):461-475.
69. Diogo M.M., da Silva C.L., Cabral J.M.S. Separation technologies for stem cell. Bioprocessing Biotechnol Bioeng 2012, 109(11).
70. Bosio A., Huppert V., Donath S., Hennemann P., Malchow M., Heinlein U.A.O. Isolation and enrichment of stem cells. Adv Biochem Engin/Biotechnol 2009, 114:23-72.
71. Kelly S.S., Sola C.B., de Lima M., Shpall E. Ex vivo expansion of cord blood. Bone Marrow Transplant 2009, 44(10):673-681.
72. Conrad P.D., Emerson S.G. Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J Leukoc Biol 1998, 64.
73. Herzog E.L., Chai L., Krause D.S. Plasticity of marrow-derived stem cells. Blood 2003, 102(10):3483-3493.
74. Zubair A.C., Silberstein L., Ritz J. Adult hematopoietic stem cell plasticity. Transfusion 2002, 42(8):1096-1101.
75. Heike T., Nakahata T. Stem cell plasticity in the hematopoietic system. Int J Hematol 2004, 79:7-14.
76. Chatterjee C.T., Sarkar C.R.S., Dhot B.P., Kumar L.C., Kumar V.V. Adult stem cell plasticity: dream or reality?. MJAFI 2010, 66:56-60.
77. Grove J.E., Bruscia E., Krause D.S. Plasticity of bone marrow-derived stem cells. Stem Cells 2004, 22(4):487-500.
78. Masson S., Harrison D.J., Plevris J.N., Newsomea P.N. Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells 2004, 22:897-907.
79. Vieyra D.S., Jackson K.A., Goodell M.A. Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev 2005, 1(1):65-70.
80. Balsam L.B., Robbins R.C. Haematopoietic stem cells and repair of the ischaemic heart. Clin Sci 2005, 109:483-492.
81. Hombach-Klonisch S., Panigrahi S., Rashedi I., et al. Adult stem cells and their trans-differentiation potential - perspectives and therapeutic applications. J Mol Med (Berl) 2008, 86(12):1301-1314.
82. Catacchio I., Berardi S., Reale A., et al. Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation. Stem Cells Int 2013, 2013:11.
83. National Cancer Institute PDQ childhood hematopoietic cell transplantation 2013, National Cancer Institute, Bethesda, MD, Available at:, accessed 14.10.03]. Date last modified November/22/2013. http://cancer.gov/cancertopics/pdq/treatment/childHCT/HealthProfessional.
84. Rogers I., Casper R.F. Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol 2004, 18(6):893-908.
85. Schwartz P.H., Bryant P.J. Therapeutic uses of stem cells. Fundmentals of stem cell debate 2008, 37-60. University of California Press Berkeley and Los Angeles, California. K.R. Monroe, R.B. Miller, J.S. Tobis (Eds.).
86. Lanza R., Moore M.A., Wakayama T., et al. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ Res 2004, 94:820-827.
87. Priddle H., Jones D.R., Burridge P.W., Patient R. Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies. Stem Cells 2005, 24:815-824.
88. Fairchild P.J., Cartland S., Nolan K.F., Waldmann H. Embryonic stem cells and the challenge of transplantation tolerance. Trends Immunol 2004, 25:465-470.
89. Baron F., Storb R., Littlea M.T. Hematopoietic cell transplantation: five decades of progress. Arch Med Res 2003, 34:528-544.
90. Luevano M., Madrigal A., Saudemont A. Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy. Cellul Mol Immunol 2012, 9(4):310-320.
91. Markiewicz M., Sobczyk-Kruszelnicka M., Mietla M.D., Koclega A., Zielinska P., Kyrcz-Krzemien S. Progress in hematopoietic stem cell transplantation. Innovations in stem cell transplantation. InTech 2013, Available from:, accessed 14.10.03. http://www.intechopen.com/books/innovations-in-stem-cell-transplantation/alternative-donor-sources-for-hematopoietic-stem-cell-transplantation, 10.5772/53083. T. Demirer (Ed.).
92. Barkholt L., Bregni M., Remberger M., Blaise D., Peccatori J., Massenkeil G., et al. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Ann Oncol 2006, 17(7):1134-1140.
93. Childs R., Chernoff A., Contentin N., Bahceci E., Schrump D., Leitman S., et al. Regression of metastatic renal cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000, 343(11):750-758.
94. Papapetrou E.P., Zoumbos N.C., Athanassiadou A. Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects. Gene Ther 2005, 12:S118-S130.
95. Serakincia N., Keith W.N. Therapeutic potential of adult stem cells. Eur J Cancer 2006, 4(2):1243-1246.
96. Smith A.G. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001, 17:435-462.